Therapeutic Asset Ratings
396 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ly3962673
Colorectal Cancer
Eli Lilly and Company
P1
C
(36)
ly3962673
Non-Small Cell Lung Carcinoma
Eli Lilly and Company
P1
C
(36)
ly3971297
Obesity Disorder
Eli Lilly and Company
P1
C
(36)
ly4050784
Cancer
Eli Lilly and Company
P1
C
(36)
ly4050784
Non-Small Cell Lung Carcinoma
Eli Lilly and Company
P1
C
(36)
ly4052031
Non-Small Cell Lung Carcinoma
Eli Lilly and Company
P1
C
(36)
ly4052031
Ovarian Cancer
Eli Lilly and Company
P1
C
(36)
ly4052031
Pancreatic Neoplasm
Eli Lilly and Company
P1
C
(36)
ly4052031
Prostate Cancer
Eli Lilly and Company
P1
C
(36)
ly4066434.
Cancer
Eli Lilly and Company
P1
C
(36)
ly4066434.
Colorectal Cancer
Eli Lilly and Company
P1
C
(36)
ly4066434.
Non-Small Cell Lung Carcinoma
Eli Lilly and Company
P1
C
(36)
ly4101174
Non-Small Cell Lung Carcinoma
Eli Lilly and Company
P1
C
(36)
ly4101174
Ovarian Cancer
Eli Lilly and Company
P1
C
(36)
ly4101174
Pancreatic Neoplasm
Eli Lilly and Company
P1
C
(36)
ly4101174
Prostate Cancer
Eli Lilly and Company
P1
C
(36)
ly41747794
Obesity Disorder
Eli Lilly and Company
P1
C
(36)
Pirtobrutinib
Plasma Cell Myeloma
Eli Lilly and Company
P1
C
(36)
ly3848575
Peripheral Neuropathy
Eli Lilly and Company
P2
NR
(0)
ly3410738
Myeloproliferative Neoplasm
Eli Lilly and Company
P1
NR
(0)
ly4337713
Pancreatic Intraductal Papillary-Mucinous Neoplasm
Eli Lilly and Company
P1
NR
(0)
Showing 376 to 396 of 396 assets
Previous
Page 16 of 16
Next
